Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Is CREB the angry bird that releases memory in Alzheimer's?

Wang A, Bibb JA.

Neuropsychopharmacology. 2011 Oct;36(11):2153-4. doi: 10.1038/npp.2011.126. No abstract available.

2.

Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease.

Yiu AP, Rashid AJ, Josselyn SA.

Neuropsychopharmacology. 2011 Oct;36(11):2169-86. doi: 10.1038/npp.2011.107. Epub 2011 Jul 6.

3.

Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.

Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K.

Brain Res. 2009 Oct 27;1295:218-29. doi: 10.1016/j.brainres.2009.07.081. Epub 2009 Jul 30.

PMID:
19646972
4.

CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.

Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22687-92. doi: 10.1073/pnas.1012851108. Epub 2010 Dec 13.

5.

Chronic Stress Decreases Basal Levels of Memory-Related Signaling Molecules in Area CA1 of At-Risk (Subclinical) Model of Alzheimer's Disease.

Alkadhi KA, Tran TT.

Mol Neurobiol. 2015 Aug;52(1):93-100. doi: 10.1007/s12035-014-8839-x. Epub 2014 Aug 12.

PMID:
25112676
6.

CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.

Moriguchi S, Tagashira H, Sasaki Y, Yeh JZ, Sakagami H, Narahashi T, Fukunaga K.

J Neurochem. 2014 Mar;128(6):927-37. doi: 10.1111/jnc.12510. Epub 2013 Nov 17.

7.

Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.

Shilling D, Müller M, Takano H, Mak DO, Abel T, Coulter DA, Foskett JK.

J Neurosci. 2014 May 14;34(20):6910-23. doi: 10.1523/JNEUROSCI.5441-13.2014.

8.

Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.

Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A, Vissel B.

PLoS One. 2013;8(4):e59586. doi: 10.1371/journal.pone.0059586. Epub 2013 Apr 1.

9.

Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.

Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N.

Eur J Pharmacol. 2013 Mar 5;703(1-3):53-61. doi: 10.1016/j.ejphar.2012.12.023. Epub 2012 Dec 28.

PMID:
23276665
10.

Presenilin dysfunction leads to memory and plasticity defects.

Hayward P.

Lancet Neurol. 2004 Jun;3(6):327. No abstract available.

PMID:
15176406
11.
12.

A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.

Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.

J Ethnopharmacol. 2011 Sep 1;137(1):783-9. doi: 10.1016/j.jep.2011.06.046. Epub 2011 Jul 5.

PMID:
21762767
13.

Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.

Volianskis A, Køstner R, Mølgaard M, Hass S, Jensen MS.

Neurobiol Aging. 2010 Jul;31(7):1173-87. doi: 10.1016/j.neurobiolaging.2008.08.005. Epub 2008 Sep 13.

PMID:
18790549
14.

Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.

Liu RT, Tang JT, Zou LB, Fu JY, Lu QJ.

Eur J Pharmacol. 2011 Nov 1;669(1-3):76-83. doi: 10.1016/j.ejphar.2011.07.051. Epub 2011 Aug 22.

PMID:
21872584
15.

Targeting the CREB pathway for memory enhancers.

Tully T, Bourtchouladze R, Scott R, Tallman J.

Nat Rev Drug Discov. 2003 Apr;2(4):267-77. Review.

PMID:
12669026
16.

Levothyroxin replacement therapy restores hypothyroidism induced impairment of L-LTP induction: critical role of CREB.

Alzoubi KH, Alkadhi KA.

Brain Res Bull. 2014 Jan;100:29-37. doi: 10.1016/j.brainresbull.2013.10.011. Epub 2013 Nov 9.

PMID:
24216002
17.

CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice.

Saura CA.

Neurodegener Dis. 2012;10(1-4):250-2. doi: 10.1159/000333341. Epub 2012 Jan 6.

PMID:
22236576
18.

Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics.

Scott Bitner R.

Biochem Pharmacol. 2012 Mar 15;83(6):705-14. doi: 10.1016/j.bcp.2011.11.009. Epub 2011 Nov 19.

PMID:
22119240
19.

CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects.

Barco A, Pittenger C, Kandel ER.

Expert Opin Ther Targets. 2003 Feb;7(1):101-14. Review.

PMID:
12556206
20.

Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease.

Perez-Cruz C, Nolte MW, van Gaalen MM, Rustay NR, Termont A, Tanghe A, Kirchhoff F, Ebert U.

J Neurosci. 2011 Mar 9;31(10):3926-34. doi: 10.1523/JNEUROSCI.6142-10.2011.

Items per page

Supplemental Content

Write to the Help Desk